Substance Use in Pregnancy-Recording

Video Transcription

Video Summary

The video covers a presentation on substance use during pregnancy, emphasizing the prevalence, impact, and strategies for intervention. The presentation identifies commonly used substances like alcohol, nicotine, and cannabis, elaborating on their effects on maternal and fetal health. It addresses misconceptions particularly around marijuana use, highlighting its potential harm due to its effect on the developing fetus and the young mother's brain. The presentation also covers the increased risk of congenital anomalies and neurodevelopmental disorders linked to alcohol use, known as fetal alcohol spectrum disorders. In discussing nicotine, the emphasis is on quitting or reducing harm through less harmful nicotine products. Opioid use is addressed with recommended treatment through agonist therapies like methadone or buprenorphine to manage withdrawal and reduce risks during pregnancy. The presentation highlights the systemic issues related to substance use, including stigma and racial disparities in treatment access due to historical policies like the war on drugs, which disproportionately affected communities of color. Methods for non-stigmatizing screening are suggested, like using person-first language and the 4Ps approach to freely discuss substance use with expecting mothers. The discussion includes the importance of not using punitive measures but supporting mothers through treatment due to the chronic nature of substance use disorders. The speaker encourages educating mothers on the risks and safe practices around breastfeeding relative to substance exposure. Finally, there's a brief discussion of the role of paternal substance use in genetic and developmental outcomes for the child.

Keywords

substance use

pregnancy

intervention strategies

maternal health

fetal health

fetal alcohol spectrum disorders

opioid treatment

stigma

racial disparities

screening methods

paternal substance use